July 18, 2017 / 10:24 PM / 5 months ago

BUZZ-Aeterna Zentaris Inc: FDA approves growth hormone drug

** Canadian drug developer’s U.S.-listed shares up 37.25 pct at $1.40 on Tuesday after market

** Stock biggest pct gainer among Nasdaq-listed stocks, set to open at more than 2-mnth high on Wed

** Company says U.S. FDA approves resubmitted marketing application of drug for treatment of adult growth hormone deficiency (AGHD), 2.5 yrs after rejecting initial marketing application

** FDA grants Prescription Drug Fee User Act (PDUFA) date of Dec 30

** Company plans drug launch in Q1 2018

** To Tuesday’s close, AEZS had fallen 71.66 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below